New Novozymes CEO Says No Plans to Alter Strategy

Jan. 21 (Bloomberg) -- Peder Holk Nielsen, who will succeed Novozymes A/S Chief Executive Officer Steen Riisgaard on April 1, talks about the company's fourth-quarter profit reported today and the outlook for technology innovation. He speaks from Copenhagen with Mark Barton on Bloomberg Television's "Countdown." (Source: Bloomberg)